A*edes (Ae.) aegypti* is the most important vector of arboviruses worldwide, due to its central role in the transmission of dengue viruses, yellow fever virus and chikungunya virus to human hosts[@b1]. To augment current control efforts such as source reduction and insecticide application, considerable effort has been put into the development of genetics-based strategies such as population replacement and reduction. Of these, population reduction programs using genetically sterilized mosquitoes have showed great promise[@b2][@b3]. In contrast, population replacement strategies have been limited to the non-transgenic introduction of beneficial *Wolbachia* endosymbionts[@b4]. One of the primary limitations in this regard has been the lack of experimentally validated gene drive mechanisms for *Ae. aegypti*, despite some dramatic success stories in both Drosophila[@b5][@b6][@b7] and *Anopheles (An.) gambiae*[@b8].

Homing endonucleases (HEs), zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), the so-called meganucleases, are able to recognize and cleave rare occurring (15--30 bp) double-stranded DNA sequences, allowing precise editing of large, complex genomes (reviewed in[@b9][@b10]). Whereas HEs are naturally occurring selfish elements, both ZFNs and TALENs are artificial hybrids of a tailored DNA binding domain and a non-specific nuclease domain. HEs can be divided into four distinct families based on their structure and mechanism of DNA binding and restriction (reviewed in[@b10]). Of these, the LAGLIDADG-type HEs (LHEs) such as I-*Sce*I, I-*Cre*I and I-*Ani*I are by far the best characterized in terms of structural information, biochemical redesign, and sequence diversity.

In most organisms, the repair of double-stranded DNA breaks (DSB) occurs through either non-homologous end-joining (NHEJ) or one of several forms of homologous recombination, such as single-strand annealing (SSA), synthesis-dependent strand invasion or gene conversion (reviewed in[@b11]). These pathways are often in competition with each other, with the choice of repair mechanism influenced by the cell cycle stage[@b12], developmental stage[@b5], and the presence and proximity of homologous sequences[@b13][@b14][@b15][@b16][@b17]. NHEJ-based repair may conservatively restore the parent sequence, but often results in the insertion or deletion of base pairs around the break site. SSA uses homology between two direct repeat sequences that flank the DSB to guide the repair process, with the result being a loss of all genetic information located between the repeats. In contrast, gene conversion-based repair using the sister chromatid or homologous chromosome is the most conservative, typically restoring the damaged region without error. Where repair during meiosis uses the homologous chromosome, the result is a loss of heterozygosity. Though possibly undesirable from the host organism\'s perspective, from the perspective of a selfish element this loss of heterozygosity represents super-Mendelian inheritance of the copied sequence.

Based on their natural tendencies to invade populations through DSB induction followed by gene conversion-based repair, HEs have been suggested as a potential gene drive system for vector-borne disease control[@b18][@b19]. Current models suggest that significant impacts on public health could be observed following the release of just a few HEs in relatively short timeframe (2--3 years[@b20]). Most excitingly, several groups have reported the successful establishment of an LHE-based gene drive system in both *D. melanogaster*[@b5][@b7] and *An. gambiae*[@b8] using I-*Sce*I. An unrelated HE, I-*Ppo*I, has been shown to induce shredding of ribosomal DNA in *An. gambiae*, leading to extensive sterility[@b21] and population crashes in large cage trials[@b22].

We have previously shown that the HEs I-*Sce*I, I-*Cre*I, I-*Ani*I and I-PpoI can induce DSBs in the *Ae. aegypti* soma when appropriate target sites are present in the mosquito genome, and that I-*Ppo*I targets the *Ae. aegypti* rDNA repeats[@b23]. In this report we show that I-*Cre*I, I-*Sce*I, and Y2-I-*Ani*I can induce DSBs at their specific target sites in the *Ae. aegypti* germline using two independent transgenic strains bearing HE target sites. Of these, the efficiency of transgene excision was substantially higher for Y2-I-*Ani*I in both cases, with 20--40% of injected survivors giving rise to progeny that had lost the target transgene. Both NHEJ- and SSA-type repair were observed, with the choice of repair associated with the presence of direct repeats in the transgene sequence. We conclude that these LHEs can edit the *Ae. aegypti* genome at useful frequencies, and are suitable scaffolds for targeted redesign efforts and the development of HE-based gene drive systems.

Results
=======

Development of a plasmid-based assay for HE function in *Ae. aegypti* embryos
-----------------------------------------------------------------------------

Initially, we designed a series of HE-expression constructs based on the *D. pseudoobscura* *hsp*82 promoter[@b24], used previously to successfully drive the expression of *Mos*1 transposase in *Ae. aegypti* embryos[@b25]. With the exception of I-*Ppo*I, where significant mortality was observed, none of the other homing endonucleases tested had detectable activity (defined as excision of the EGFP reporter gene) in this system (data not shown). Therefore, we sought to identify alternative promoters with higher activity in the early embryo. Using a dual luciferase reporter assay, we examined the ability of three additional promoters, the baculovirus IE1 promoter and *Ae. aegypti* *polyubiquitin* (*PUb*) and *Ub~L40~*promoters[@b26], to drive gene expression at various times following injection into pre-blastoderm embryos. At early (2--4 hr); mid (12--24 hr) and late (48--72 hr) timepoints, expression from the *PUb* promoter significantly exceeded expression from the each of the other promoters (*P* \< 0.05 Mann-Whitney test, Bonferroni correction based on 15 tests; [Fig. 1](#f1){ref-type="fig"}). Maximum expression from the *PUb* promoter was achieved just 2--4 hr after injection, while with the IE-1 and *Ub~L40~* promoters expression did not peak until 12 hr. Therefore we placed each HE ORF downstream of the *Ae. aegypti* *PUb* promoter to analyze embryonic and germline endonuclease activity*.*

To test the ability of HEs to introduce double-stranded DNA breaks in early stage mosquito embryos, we co-injected each *PUb*-HE expression construct with a single-stranded annealing (SSA)-dependent luciferase reporter, wherein the first 300 bp of the firefly luciferase ORF was duplicated ([Fig. 2A](#f2){ref-type="fig"}). A series of stop codons, along with the recognition sequence for each HE, was placed in the intervening spacer region. In all three cases (Y2-I-*Ani*I, I-*Sce*I, I-*Cre*I), injection of a *PUb*-HE expression construct resulted in a significant increase in firefly luciferase expression compared to embryos injected with a non-specific control construct, *PUb*-EGFP ([Fig. 2B](#f2){ref-type="fig"}). However, expression of Y2-I-*Ani*I induced significantly more luciferase expression than either I-*Sce*I or I-*Cre*I, which did not differ from each other. We conclude that all three HEs are active in the early embryos of *Ae. aegypti*, and thus may be capable of catalyzing DSBs in the germline of this mosquito.

Germline excision by homing endonucleases in line *PUb*-EGFP \#P5
-----------------------------------------------------------------

To determine whether HEs were able to catalyze the excision of *Ae. aegypti* genomic segments in a heritable manner, HE expression constructs were injected individually into the embryos of a transgenic strain (P5) containing a *PUb*-EGFP cassette flanked by the recognition sequences for each HE[@b26], as well as a 3xP3-DsRED cassette ([Fig. 3A, B](#f3){ref-type="fig"}). Surviving individuals were pooled, mated to an unmarked strain (*kh^w^*) and offered a bloodmeal; progeny were screened as larvae for the presence/absence of each fluorescent marker ([Table 1](#t1){ref-type="table"}). Progeny that had lost expression of the EGFP marker were identified at varying frequencies for HEs I-*Cre*I, I-*Sce*I and Y2-I-*Ani*I ([Table 1](#t1){ref-type="table"}). Progeny that had lost EGFP were detected in all four Y2-I-*Ani*I pools, and comprised 2--4% of the total progeny. Excision of EGFP by I-*Sce*I (4/8 pools) and I-*Cre*I (1/6 pools) appeared to be less efficient. No evidence of transgene excision was seen in the few survivors of I-*Ppo*I injection, or in the absence of HE.

Sequencing the remaining transgene sequences in the progeny that had lost EGFP confirmed complete loss of the *PUb*-EGFP gene cassette and revealed that both NHEJ and SSA were used as repair mechanisms to different extents ([Fig. 3](#f3){ref-type="fig"}). For Y2-I-*Ani*I, we obtained 47 sequences corresponding to at least nine independent events that appeared to result from NHEJ following Y2-I-*Ani*I-induced DSBs at both the upstream and downstream recognition sites ([Fig. 3A, C](#f3){ref-type="fig"}). Of these, 14 sequences (3 events) corresponded with perfect repair, restoring a single I-*Ani* recognition site. The remaining events were characterized by small deletions or insertions ([Fig. 3C](#f3){ref-type="fig"}). In these instances, independent events were defined as having a distinct modified transgene sequence, or as being derived from independent G~0~ pools. The introduction of a single DSB could also be followed by SSA-based repair, resulting in the collapse of direct repeat sequences. In line P5, the largest direct repeat sequence consisted of the SV40 3\'UTR (240 bp), which followed each of the EGFP and DsRED ORFs. All progeny having lost EGFP from the I-*Sce*I experiment were found to result from the collapse of these two repeats ([Fig. 3D](#f3){ref-type="fig"}). SSA-based collapse of SV40 repeats also was commonly observed for Y2-I-*Ani*I. However, in this case, most of the sequenced mosquitoes contained small deletions or insertions at the remaining I-*Ani*I site. We interpret this as the result of SSA-based repair, followed by further cleavage by Y2-I-*Ani*I and subsequent NHEJ-based repair ([Fig. 3D](#f3){ref-type="fig"}). While most SSA-repair utilized the SV40 repeats, we recovered at least four instances where other HE recognition sites were used in the SSA response (while the order of these sites is scrambled in each cluster, they remain organized as direct repeats). Thus, even sequences as short as 18--20 bp can direct the SSA repair response.

While almost all of the progeny recovered displaying a phenotypic change were found to be DsRED^+^/EGFP^−^, a few instances in which a DsRED marker was lost were identified. Of these, one (a single I-*Cre*I larvae) died early in development and we were unable to determine the nature of the excised region. However, a large deletion (and small insertion) spanning the entire 3xP3-DsRED gene cassette was identified ([Fig. 3E](#f3){ref-type="fig"}) in two individuals derived from the I-*Sce*I experiment. As there were no sequences homologous with the transgenic construct at these locations, we classified these as NHEJ events.

Germline excision by homing endonucleases in line 3xP3-RG \#P11A
----------------------------------------------------------------

Local chromosomal structure may influence the accessibility of HEs to their target sites, and thus may affect the rate of DSB formation. Therefore, we repeated our experiments using a second recipient line (P11A), containing another double-marked transgene ([Fig. 4A, B](#f4){ref-type="fig"}). Inverse PCR revealed that the P11A insertion mapped to a different genomic scaffold than line P5, though both were incorporated into the large intronic regions of protein-coding genes ([Table S1](#s1){ref-type="supplementary-material"}). Progeny found to have lost the expression of at least one of the two markers were recovered following injection with Y2-I-*Ani*I and I-*Cre*I, but not with I-*Sce*I or I-*Ppo*I ([Table 2](#t2){ref-type="table"}). Interestingly, of those showing a loss of marker gene expression, injection of I-*Cre*I resulted in mostly G^+^/R^−^ progeny, while Y2-I-*Ani*I produced mostly G^−^/R^+^ progeny. A class of progeny that had lost both marker genes was recovered only following Y2-I-*Ani*I injection. Once again, survival of I-*Ppo*I mosquitoes was extremely low.

Consistent with previous data from line P5, we observed both NHEJ ([Fig. 4C](#f4){ref-type="fig"}) and SSA type repair ([Fig. 4D](#f4){ref-type="fig"}) resulting in the loss of transgene segments following injection with Y2-I-*Ani*I. Once again, when SSA-directed repair was used, most sequenced individuals contained small deletions at the remaining I-*Ani*I recognition site, indicating additional cutting by Y2-I-*Ani*I following the initial repair event. For Y2-I-AniI, the SSA pathway primarily utilized the SV40 direct repeats (7 events) flanking the upstream I-*Ani*I site to direct the repair process. Two additional SSA repair events were found based on the *loxP* and I-*Sce*I repeats present in the transgene construct. In contrast, all I-*Cre*I-mediated events were found to be the result of SSA-repair resulting in the collapse of the \~260 bp 3xP3 promoter (3 events) or the 35 bp *loxP* sites (3 events), with no evidence for NHEJ ([Fig. 4A](#f4){ref-type="fig"}). Attempts to identify the genetic basis for the R^−^/G^−^ phenotypes seen in the Y2-I-*Ani*I experiment were unsuccessful, as it appeared that the entire transposon construct, and an unknown quantity of the surrounding chromosomal DNA had been lost. As the G~1~ individuals were only hemizygous for the transgene insertion, PCR using primers outside of the transgene sequence was confounded by the presence of the alternate, wild-type allele. The lack of such R^−^/G^−^ individuals from the other three experiments argues against a more mundane explanation such as incomplete homozygosity in the parental strain with respect to the transgene insertion (all injections were performed from a single parental cage), and suggests HEs may also trigger larger scale deletions of chromosomal segments.

For both the P5 and P11A experiments, we calculated the minimum HE excision frequency, defined as the number of independent excision events per fertile G~0~ individual ([Table 3](#t3){ref-type="table"}). Y2-I-*Ani*I proved the most effective in both genetic backgrounds, with 20--40% of fertile G~0~ individuals producing at least one offspring bearing an excision event ([Table 3](#t3){ref-type="table"}). While both I-*Sce*I and I-*Cre*I were also able to catalyze transgene excision, they did so at a reduced rate and in a manner that appeared to be more dependent on the transgene structure and/or insertion site.

Discussion
==========

Two different transgenic lines were used to determine the ability of four HEs to perform site-specific excision of gene segments in the *Ae. aegypti* germline. Of these, Y2-I-*Ani*I gave the most useful frequencies of transgene excision, followed by both I-*Cre*I and I-*Sce*I. Both of the target transgenes in our study were found to have integrated into the large intronic space of a gene. While HE-based editing at both of these locations was highly effective, additional target sites within tightly wound heterochromatic space would be required to determine if such local structure poses a substantial barrier to HE-based targeting. However, for most downstream applications HE-based gene targeting efforts are likely to focus on euchromatic regions.

Embryonic survival following I-*Ppo*I injection was substantially lower (\~1%) than that of the other HEs used in this study. This was not unexpected, given that I-*Ppo*I has a substantial number of recognition sites within the 28S rDNA repeats of *Ae. aegypti*[@b23] and has been shown to shred the rDNA of *An. gambiae* leading to early embryonic lethality[@b21][@b22][@b27]. We reasoned that the few survivors from these injections may still produce excision events due to receiving a sub-lethal dose, but this was not observed. This may be due to the fact that I-*Ppo*I sites within the rDNA (n \> 300) vastly outnumber those in the transgene (n = 2), making it impossible to titrate to a level where rDNA shredding was avoided yet recoverable cleavage events at the test locus could be obtained. Embryonic survival following injection with Y2-I-*Ani*I, I-*Cre*I and I-*Sce*I ranged from 10--17%, similar to what we typically observe following injection of transposon-based DNA constructs[@b26][@b28][@b29], suggesting that these HEs recognize few (if any) cryptic off-target sites in the *Ae. aegypti* genome.

Sequencing of the transgene following HE-induced DSBs revealed the footprint of both NHEJ and SSA-based repair processes. We note that gene conversion-based repair would result in the restoration of the lost transgene sequence, and would be phenotypically invisible in our assay; thus all excision frequencies we report likely underestimate the magnitude of HE-induced DSB formation. The method of DNA repair we observed varied based on both the HE and the structure of the target transgene. It is well-established that these two repair methods are in competition, and that the presence and proximity of direct repeats can influence the decision for repair to proceed via NHEJ or SSA (reviewed in[@b11]). Both transgenes contained a number of direct repeats that varied in length from 18--260 bp, and a single DSB introduced at either cluster would leave at least one viable SSA-based repair option. For example, following I-*Sce*I injection into line P5, we only observed SSA-based repair at the SV40 direct repeats. This suggests that only a single DSB occurred in the upstream cluster (a similar break at the downstream cluster would leave both SV40 repeats upstream of the break). Simultaneous induction of DSBs at both the upstream and downstream clusters would eliminate one of the repeats, and thus might favor NHEJ as observed for Y2-I-*Ani*I. Similarly, all I-*Cre*I induced excision events were associated with SSA repair centered on the 3xP3 or *loxP* repeats, consistent with the induction of a single DSB at either the upstream or downstream clusters, respectively. Interestingly, I-*Cre*I induced DSBs in the upstream cluster of the P11A transgene were only associated with collapse of the 3xP3 repeats, whereas this was not observed for Y2-I-*Ani*I, whose action instead led primarily to the choice of SV40 repeats (*P* \< 0.01, Fisher\'s Exact Test). One possible explanation is that the I-*Cre*I recognition site in the upstream cluster was immediately adjacent to the second 3xP3 repeat. Thus the speed of resection and proximity of each repeat to the end of the DSB may dictate the ultimate choice of homologous sequence used for repair[@b13][@b14]. We note that the type of repair can also be strongly influenced by the developmental stage when DSB induction occurs[@b5][@b7], and thus the expression of these same HEs at later points in development (or in the soma) might alter the chosen method of repair. Further exploration of this using the HE-based system we have developed would be an interesting platform to explore the mechanisms of DSB repair in *Ae. aegypti*, whose genome is rich in short repetitive elements.

The LHEs Y2-I-*Ani*I, I-*Cre*I and I-*Sce*I have all been successfully redesigned through a variety of approaches to recognize new target sequences[@b8][@b30][@b31][@b32][@b33][@b34][@b35][@b36]. In particular, Y2-I-*Ani*I and I-*Cre*I were successfully altered to recognize sequences in the *An. gambiae* genome[@b8]. Our data indicate that the Y2-I-*Ani*I scaffold (or its close relatives[@b37]) may be the best suited for targeted redesign experiments involving precise gene editing in *Ae. aegypti*. Extensive sequencing and structural analysis has revealed many more active LHE members[@b38], providing additional scaffolds as potential starting material for redesign efforts. While testing a large number of variant LHEs or a large pool of newly described scaffolds in germline-based experiments is likely not feasible, we note that data obtained from our transient SSA assay were highly predictive of success in the more time-consuming germline experiments. Thus, we anticipate that candidate HEs based on the Y2-I-*Ani*I or other scaffolds validated in simple yeast-based assays[@b39] can subsequently be tested for the potential to edit the mosquito genome in a more medium to high-throughput manner (1--3 test constructs per day) compared to what is possible with germline-based experiments (2--3 months per test construct).

The recent success of TALENs in editing a wide range of genomic targets at high efficiency, combined with the almost complete modularity of TALE sequence recognition is already leading to their adoption over other technologies such as ZFNs and LHEs[@b9][@b40]. However, there are clear situations where LHEs remain the preferred choice due to their small size and extreme target specificity[@b10]. One such application may be the development of genetics-based control strategies for vector-borne disease agents such as dengue viruses. Such strategies depend on the ability to achieve super-Mendelian inheritance of one or more transgene sequences[@b41]. This gene drive may be coupled to an anti-pathogen gene(s), resulting in the conversion of a competent vector population to an incompetent one, or used alone to inactivate one or more essential genes, resulting in a population crash[@b20]. Effective laboratory-based gene drive systems using maternal lethality/embryonic rescue[@b6] and LHEs[@b5][@b7] have been successfully demonstrated in model systems such as Drosophila and in the malaria mosquito[@b8], yet this has not been achieved in *Ae. aegypti*. We conclude that HEs such as Y2-I-*Ani*I (or its variants) should be considered as strong candidates for evaluation in gene drive experiments in this important disease vector species.

Methods
=======

Plasmid construction and Luciferase assays
------------------------------------------

Plasmids pGL3-IE1, pGL3-*Ub~L40~* and pGL3-*PUb* were described previously[@b26]. To generate pGL3-*hsp*82, a 992-bp region containing the *Drosophila pseudoobscura* *hsp*82 promoter was amplified by polymerase chain reaction (PCR) from pK*hsp*82[@b24] using the primers 5′-TTTTCCAGTTGTTTTAATTTAACAGCAGAG-3′ and 5′-TTTTAAGCTTATGGATTTTTACCATATTATTA-3′. All PCR reactions were performed using Platinum Pfx (Invitrogen, Carlsbad, CA) as follows: 94°C for 2 mins, 94°C for 15 s, 65°C for 30 s, 68°C for 70 s, 35 cycles, 68°C for 10 mins. Amplicons were digested with *Hind*III and *Nco*I (NEB, Ipswich, MA), purified, and ligated into the corresponding sites of pGL3-Basic (Promega, Madison, WI). The normalization control plasmid pRL-CMV-Renilla was purchased from Promega.

The *PUb-*HE (I-*Cre*I, I-*Sce*I and I-*Ppo*I) expression vectors were generated using pK*hsp*82-HE plasmids[@b23] as a template and primers 5′-ttttccatggTTAAATTAAAACACGGATCCATGC-3′ and R 5′-ttttgcggccgcGATCTTGATCTTCATGGTCGACG-3 in order to add *Nco*I and *Not*I restriction sites (underlined bases). Plasmid pSLfa-*PUb*-EGFP-SV40[@b26] was digested with *Nco*I and *Not*I to remove the EGFP coding region; all three homing endonuclease genes were ligated into these sites to generate pSLfa/*PUb*-I-*Cre*I, pSLfa/*PUb*-I-*Sce*I, pSLfa/*PUb*-I-*Ani*I, and pSLfa/*PUb*-I-*Ppo*I. pSLfa/*PUb*-*Y2-*I*-Ani*I was produced using the QuikChange II-E Site-Directed Mutagenesis Kit (Stratagene) to introduce the F13Y and S111Y mutations described by Takeuchi et al[@b42].

For luciferase experiments, the experimental plasmid (pGL3*-PUb*, pGL3*-Ub~L4~*~0~, pGL3-*IE1*, pGL3-*hsp82* or pGL3 Basic) and normalization control plasmid (pRL-*CMV*) were co-injected at 0.3 μg/μl each into *Aedes aegypti* Liverpool strain embryos (G~0~). Three replicates of 100-120 embryos each were injected with each promoter construct. Injected embryos were snap-frozen in liquid nitrogen at 2, 4, 12, 24, 48 and 72 hours post injection. Embryos were homogenized in the lysis buffer provided by the manufacturer (Promega, Madison, WI). Activity of both Firefly luciferase (FF-luc) and Renilla luciferase (R-luc) were determined by using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI) with a GloMax 20/20 instrument according to the manufacturer\'s protocol.

Mosquito strains and microinjections
------------------------------------

*Ae. aegypti* Liverpool, *kh^W^*, *PUb*-EGFP line \#P5[@b26] and transgenic line 3xP3-RG \#P11A were maintained as previously described[@b28]. For embryonic microinjections, 0.3 μg/μl of pSLfa/*PUb*-Y2-I-*Ani*I, pSLfa/*PUb*-I-*Sce*I, pSLfa/*PUb*-I-*Cre*I or pSLfa/*PUb*-I-*Ppo*I in 1× injection buffer[@b25] was injected separately into 1 hour old embryos of transgenic lines *PUb*-EGFP line \#P5 or 3xP \#-RG P11A. Eggs were hatched 5 days post injection and surviving G~0~females were merged into pools of 20--25 individuals and mated to *kh^w^* strain males. G~0~males were mated individually to 5 *kh^w^* females for 2--3 days and pooled prior to blood feeding and egg collection. G~1~ larvae were screened using a fluorescent Leica MZ16F microscope for presence/absence of marker genes (DsRed or EGFP).

Analysis of DSB repair events
-----------------------------

To identify cleavage events in the transgenes from *PUb*-EGFP line \#P5, primers 5′-CGCCACCACCTGTTCCTGTA-3′ and 5′-CTCTCAGTGCAGTCAACATGTCGAG-3′ were used to amplify the target region from genomic DNA for DsRED positive, EGFP negative individuals (G^−^R^+^). PCR conditions were: 94°C for 2 mins, 94°C for 30 s, 60°C for 30 s, 68°C for 3.5 min, 35 cycles, 68°C for 10 min using Platinum *Pfx* (Invitrogen, Carlsbad, CA). For G~1~ individuals scored as EGFP positive, DsRED negative (G^+^R^−^), primers 5′-CTTACTTCCAACTGCTCTGCGA-3′ and 5′-CTTTGTTCACTCTGAAATTTTCTCCTCTGGC-3′ were used with the same amplification conditions. To identify cleavage events in line 3xP3-RG \#P11A, primers 5′-AAGTGGTGATTTTGACGTCGACGAGATCGG-3′ and 5′-TACCACCAAGCTGTCAGTTCCAAC-3′ (G^−^R^+^; 94°C for 2 min, 94°C for 30 s, 67°C for 30 s, 68°C for 2 min, 35 cycles, 68°C for 10 min) or 5′-TTGCCGGTGGTGCAGATGAACTTCAGG-3′ and 5′-CTTACTTCCAACTGCTCTGCGA-3′ (G^+^R^−^; 94°C for 2 min, 94°C for 30 s, 60°C for 30 s, 68°C for 2 min, 35 cycles, 68°C for 10 min) were used. All amplicons were gel purified and sequenced directly.
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![Transcriptional activity of *IE1, Ub~L40~*, *PUb* and *hsp82* promoters in *Ae.* *aegypti* embryos.\
The ratio of Firefly (FL) to Renilla (RL) luciferase activity for each experimental promoter was compared with no-promoter control plasmid (pGL3) following injection into *Ae. aegypti* embryos. Error bars indicate the standard deviation amongst 3-6 biological replicates, with each replicate consisting of approximately 100 injected embryos.](srep01603-f1){#f1}

![Embryo-based single-strand annealing (SSA) assay.\
(A) Schematic representation of the SSA test construct injected into *Ae. aegypti* embryos along with the specified *PUb*-HE expression vector; successful cleavage of the HE target site followed by SSA-based repair restores the FF-luc ORF. (B) Ratio of Firefly (FL) to Renilla (RL) luciferase (24 hr) following injection into pre-blastoderm embryos. Error bars indicate the standard deviation; each point represents a group of \~100 injected embryos. Statistical significance between pairs was determined using the Mann-Whitney test; \*\* indicates *P* \< 0.01.](srep01603-f2){#f2}

![HE-catalyzed germline excision in *Aedes aegypti* transgenic line *PUb*-EGFP \#P5.\
(A) Schematic representation of the parental transgene insertion. The dual transgene construct contained two HE clusters flanking the *PUb*-EGFP cassette; the order of HE sites differed between the upstream (blue) and downstream (red) clusters. Connectors indicate the boundaries of excised sequence by Y2-I-*Ani*I or I-*Sce*I. The initial repair mechanism is indicated (NHEJ, black connector; SSA, gray connector), along with the HE used, the number of sequences obtained (n) and with the minimum number of independent occurences (shown in parentheses). (B) Mosquito larvae photographed using a DsRED (top) or EGFP (bottom) filter. DsRED/EGFP positive (R^+^ or G^+^) and negative (R^−^ or G^−^) individuals are indicated; fluorescent signal in the eyes is indicated by the arrowhead. (C) Sequences obtained corresponding to NHEJ events following injection of Y2-I-*Ani*I or I-*Sce*I compared to a hypothetical (Hyp) sequence whereby the two I-*Ani*I sites are cut and joined together perfectly. (D) Sequences obtained corresponding to SSA-based repair events compared to a hypothetical (Hyp) sequence where the two SV40 direct repeats are collapsed. (E) Large deletion of the 3xP3-DsRED-SV40 cassette. For C-E, numbers indicate the number of sequences obtained, with the minimum number of unique occurrences in parentheses.](srep01603-f3){#f3}

![HE-catalyzed germline excision in *Aedes aegypti* transgenic line 3xP3-RG \#P11A.\
(A) Transgenic construct for line P11A. Connectors indicate NHEJ (black) or SSA (gray) based repair following deletion of the intervening segment. (B) Mosquito larvae from line P11A photographed using a DsRED (top) or EGFP (bottom) filter. DsRED/EGFP positive (R^+^ or G^+^) and negative (R^−^ or G^−^) individuals are indicated; fluorescent signal in the eyes is indicated by the arrowhead. Sequences obtained following NHEJ (C) or SSA (D) -based repair. For each, the number of sequenced mosquitoes (n) along with the minumum number of unique occurrences (in parentheses) are indicated.](srep01603-f4){#f4}

###### HEs catalyze germline excision of genome segments in *PUb*-EGFP line \#P5

                                                                     \# of G~1~ individuals[b](#t1-fn2){ref-type="fn"}  
  ------------- ------- ------------- ----------- ----------------- --------------------------------------------------- ---
  I-*Cre*I       1,100   149 (13.5%)       4       2/2,800 (0.07%)                           1                           1
                                       1--3;5--6      0/11,800                               0                           0
  Y2-I-*Ani*I    1,010   100 (9.9%)        1       46/1,200 (3.8%)                          46                           0
                                           2       66/1,500 (4.4%)                          66                           0
                                           3       70/2,900 (2.4%)                          70                           0
                                           4        4/800 (0.5%)                             4                           0
  I-*Sce*I       1,170   199 (17.0%)       1       2/1,500 (1.3%)                            0                           2
                                           2       1/3,000 (0.03%)                           1                           0
                                           6       38/3,300 (1.1%)                          38                           0
                                           7       5/3,600 (0.14%)                           5                           0
                                        3--5;8        0/10,700                               0                           0
  I-*Ppo*I       1,050    13 (1.2%)       1−2          0/2,300                               0                           0

^a^indicates the number of G~1~ offspring displaying a loss of one marker gene, along with the total number of individuals examined.

^b^G~1~ individuals separated by loss of EGFP (G^−^/R^+^) or DsRED (G^+^/R^−^) phenotypes.

###### Germline excision of genome segments in transgenic line 3xP3-RG \#P11A

                                                              \# of G~1~ individuals[b](#t2-fn2){ref-type="fn"}       
  ------------- ------ ------------- ------ ---------------- --------------------------------------------------- ---- ----
  I-*Cre*I       1010   105 (10.6%)    1     50/1250 (4.0%)                           9                           41   0
                                       2     10/1400 (0.7%)                          10                           0    0
                                       3     7/2150 (0.3%)                            3                           4    0
                                       4     77/2550 (3.0%)                           0                           77   0
  Y2-I-*Ani*I    1090   110 (10.1%)    1     26/1350 (1.9%)                          20                           1    5
                                       2     50/1000 (5.0%)                          43                           4    3
                                       3     49/1900 (2.6%)                          34                           0    15
                                       4     79/1650 (4.8%)                          76                           0    3
                                       5     15/1700 (0.9%)                          15                           0    0
  I-*Sce*I       1000   110(11.0%)    1--4       0/6400                               0                           0    0
  I-*Ppo*I       1100    14 (1.2%)    1--2       0/2650                               0                           0    0

^a^indicates the number of G~1~ offspring displaying a loss of one or both marker genes, along with the total number of individuals examined.

^b^G~1~ individuals phenotyped by loss of EGFP only (G^−^/R^+^), DsRED only (G^+^/R^−^), or both EGFP and DsRED (G^−^/R^−^).

###### Minimum HEs excision frequency and number of independent repair mechanisms in two transgenic lines

                  P5    P11A                                 
  ------------- ------ ------ ------ ------ -------- --- --- ---
  Y2-I-*Ani*I    40%     6      9      5      22%     4   3   5
  I-*Sce*I        4%     3      1      0     \<1.8%   0   0   0
  I-*Cre*I       2.7%   0--2   0--2   0--2   11.4%    6   0   0

\*defined as the ratio of independent events per fertile G~0~ survivor.
